Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of the International AIDS Society
Published in: Journal of the International AIDS Society 4/2010

Open Access 01-12-2010 | Oral presentation

O212. Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis

Authors: WFW Bierman, EH Humphreys, MA van Agtmael, CA Boucher, GW Rutherford

Published in: Journal of the International AIDS Society | Special Issue 4/2010

Login to get access

Excerpt

Ritonavir-boosted protease inhibitor (PI/r) monotherapy has several potential benefits over standard PI-based combination antiretroviral therapy (cART) and has recently been included in the European HIV treatment guidelines. However, there are concerns about its efficacy. We performed a meta-analysis comparing PI/r monotherapy to cART to examine its efficacy. …
Metadata
Title
O212. Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis
Authors
WFW Bierman
EH Humphreys
MA van Agtmael
CA Boucher
GW Rutherford
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-13-S4-O18

Other articles of this Special Issue 4/2010

Journal of the International AIDS Society 4/2010 Go to the issue

Poster presentation

Evaluating pharmacist involvement in HIV outpatient clinics: can medication histories, drug interaction checks and adherence assessments add benefit?

Poster presentation

A high occurrence of late presenters and missed HIV diagnosis in clinical care in Sweden

Oral presentation

Adolescents with perinatally acquired HIV — coming your way

Poster presentation

Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin

Poster presentation

Cost-effectiveness of 2NRTI+NNRTI versus 2NRTI+PI as the initial cART regimen

Poster presentation

Efavirenz use and contraceptive methods in HIV-positive women in a large urban cohort

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits